ARCHIVES

Avastin improves lung cancer survival, opens options for new combinations. Details of Avastin risk vs. benefit to be released at ASCO annual meeting.

This article is from The Cancer Letter archive.

Vol. 31 No. 13 | April 1, 2005

Download PDF Visit The Full Archive

Related Articles

ONS Forms More Special Interest Groups For Members

May 11, 1990

BMS Demands Resignation Of Two ImClone Executives

February 8, 2002

NCI Puts $36 Million In Stimulus Funds Towards Early Clinical Trials

September 4, 2009

Low-Dose Warfarin Prevents Blood Clots, NIH Study Finds

February 28, 2003

FDA Approves Abraxane And Alimta for NSCLC

October 26, 2012

Cancers Linked To Agent Orange In IOM Review

August 13, 1993